Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.96%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.23Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information
Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTNOVABAY PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NBY - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 283K | 5.96% | $ 4.75M |
| 3/31/2025 | $ 424K | 5.93% | $ 7.15M |
| 12/31/2024 | $ 381K | 3.9% | $ 9.78M |
| 9/30/2024 | $ 336K | 3% | $ 11.2M |
| 6/30/2024 | $ 292K | 2.43% | $ 12.02M |
| 3/31/2024 | $ 164K | 1.15% | $ 14.23M |
| 12/31/2023 | $ 203K | 1.38% | $ 14.73M |
| 9/30/2023 | $ 276K | 1.88% | $ 14.64M |
| 6/30/2023 | $ 344K | 2.26% | $ 15.2M |
| 3/31/2023 | $ 413K | 3.03% | $ 13.64M |
Key Performance Insights, Last 5 Years
- NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 0.56%.
- Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average DepAmor % has been 2.39%.
- The median DepAmor % for NOVABAY PHARMACEUTICALS INC during this period was 2.35%
- NOVABAY PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 5.96%.
- The lowest DepAmor % recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe 0.47%
NOVABAY PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for NOVABAY PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 55K ] / Revenues [ $ 9.75M ]
(=) DepAmor % [ 0.56% ] NBY - Depreciation and Amortization Margin, Last 5 years
0.47%
Minimum
Mar 31, 2021
5.96%
Maximum
Jun 30, 2025
2.39%
Average
2.35%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |